Cargando…

Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort

OBJECTIVE: Fecal immunochemical tests (FITs) for hemoglobin in stool are increasingly used for colorectal cancer screening. Reported sensitivities and specificities have strongly varied between studies, but it is unclear to what extent such variation reflects differences between tests or between stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, Hermann, Qian, Jing, Werner, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896664/
https://www.ncbi.nlm.nih.gov/pubmed/29670403
http://dx.doi.org/10.2147/CLEP.S155548
_version_ 1783313857239842816
author Brenner, Hermann
Qian, Jing
Werner, Simone
author_facet Brenner, Hermann
Qian, Jing
Werner, Simone
author_sort Brenner, Hermann
collection PubMed
description OBJECTIVE: Fecal immunochemical tests (FITs) for hemoglobin in stool are increasingly used for colorectal cancer screening. Reported sensitivities and specificities have strongly varied between studies, but it is unclear to what extent such variation reflects differences between tests or between study population characteristics. We aimed to evaluate the key parameters of FIT performance for detecting advanced neoplasia (AN) according to sex and age. METHODS: Sex- and age-specific sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPVs) for detecting AN of a quantitative FIT (FOB Gold®) were evaluated among 3211 men and women aged 50–79 years who underwent screening colonoscopy in Germany. RESULTS: At the cutoff recommended by the manufacturer (17 µg hemoglobin/g feces), sensitivity was higher (51.2% versus 34.7%, p=0.004) and specificity was lower (91.0% versus 94.8%, p<0.001) among 65–79 year-old participants compared with 50–64 year-old participants. PPVs and NPVs did not differ significantly between age groups. However, higher NPVs were observed among women compared with men (94.7% versus 92.5%, p=0.015). Specificity was also higher among women compared with men (94.7% versus 92.3%, p=0.007), while there was only a little variation in sensitivity (40.3% versus 41.8%, p=0.789) according to sex. In joint stratification by both factors, sensitivity ranged from 34.1% (95% CI 24.2%–45.2%) in 50–64 year-old women to 51.4% (95% CI 39.3%–63.3%) in 65–79 year-old men (p=0.029). The observed age and sex differences were highly consistent across a wide range of alternative cutoffs from 10 to 50 µg hemoglobin/g feces. CONCLUSION: There are major differences in diagnostic performance parameters according to sex and age, which should receive careful attention in the interpretation and comparison of results of FIT-based colorectal cancer screening studies.
format Online
Article
Text
id pubmed-5896664
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58966642018-04-18 Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort Brenner, Hermann Qian, Jing Werner, Simone Clin Epidemiol Original Research OBJECTIVE: Fecal immunochemical tests (FITs) for hemoglobin in stool are increasingly used for colorectal cancer screening. Reported sensitivities and specificities have strongly varied between studies, but it is unclear to what extent such variation reflects differences between tests or between study population characteristics. We aimed to evaluate the key parameters of FIT performance for detecting advanced neoplasia (AN) according to sex and age. METHODS: Sex- and age-specific sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPVs) for detecting AN of a quantitative FIT (FOB Gold®) were evaluated among 3211 men and women aged 50–79 years who underwent screening colonoscopy in Germany. RESULTS: At the cutoff recommended by the manufacturer (17 µg hemoglobin/g feces), sensitivity was higher (51.2% versus 34.7%, p=0.004) and specificity was lower (91.0% versus 94.8%, p<0.001) among 65–79 year-old participants compared with 50–64 year-old participants. PPVs and NPVs did not differ significantly between age groups. However, higher NPVs were observed among women compared with men (94.7% versus 92.5%, p=0.015). Specificity was also higher among women compared with men (94.7% versus 92.3%, p=0.007), while there was only a little variation in sensitivity (40.3% versus 41.8%, p=0.789) according to sex. In joint stratification by both factors, sensitivity ranged from 34.1% (95% CI 24.2%–45.2%) in 50–64 year-old women to 51.4% (95% CI 39.3%–63.3%) in 65–79 year-old men (p=0.029). The observed age and sex differences were highly consistent across a wide range of alternative cutoffs from 10 to 50 µg hemoglobin/g feces. CONCLUSION: There are major differences in diagnostic performance parameters according to sex and age, which should receive careful attention in the interpretation and comparison of results of FIT-based colorectal cancer screening studies. Dove Medical Press 2018-04-05 /pmc/articles/PMC5896664/ /pubmed/29670403 http://dx.doi.org/10.2147/CLEP.S155548 Text en © 2018 Brenner et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Brenner, Hermann
Qian, Jing
Werner, Simone
Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
title Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
title_full Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
title_fullStr Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
title_full_unstemmed Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
title_short Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
title_sort variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896664/
https://www.ncbi.nlm.nih.gov/pubmed/29670403
http://dx.doi.org/10.2147/CLEP.S155548
work_keys_str_mv AT brennerhermann variationofdiagnosticperformanceoffecalimmunochemicaltestingforhemoglobinbysexandageresultsfromalargescreeningcohort
AT qianjing variationofdiagnosticperformanceoffecalimmunochemicaltestingforhemoglobinbysexandageresultsfromalargescreeningcohort
AT wernersimone variationofdiagnosticperformanceoffecalimmunochemicaltestingforhemoglobinbysexandageresultsfromalargescreeningcohort